Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOBINIZADEH MOHAMMADREZA; AKBARISARI ALI; Olyaeemanesh Alireza; MOHAMMADSHAHI MARITA; AHMADNEZHAD ELHAM; ABOEE PARISA; Fakorfard Zeinab; SADEGHI RAHELEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF PHARMACEUTICAL CARE Year:2022 | Volume:10 | Issue:3 Page(s): 146-150

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review

Author(s)

Keywords

Molnupiravir

Covid-19

Review

Abstract

In the first stage of viral replication, Covid-19 may cause a remarkable inflammatory response in patients. Molnupiravir is an oral antiviral medicine which functions through inhibiting the viral replication of RNA viruses including Corona virus (SARS-CoV-2). The present study intends to help the policymakers decide on using of this medication in Iran. This study is conducted on Jan. 22, 2022 (from Jan. 2014-the year of Molnupiravir production for treatment of RNA virus diseases), using a rapid Review of evidence as well as Reviewing reliable databases including the Cochrane library, PubMed and Google scholar. The inclusion criteria were the randomized controlled trials that investigated the safety and efficacy of Molnupiravir at different doses in patients with Covid-19, comparing with placebo or other routine care methods (Population: Covid-19 patients, Intervention: Molnupiravir, Control: placebo or other routine care methods, Outcome: Safety, Efficacy and Economic status, Study design: the randomized controlled trials or HTA reports). Prescription for oral administration in 800 mg dose twice daily for 5 days to inpatients and outpatients with mild, moderate or severe symptoms in the early stages of the disease (viral phase) had the most desirable level of efficacy. This medicine has no serious side effects,since the mutations caused by this medication have not been clarified yet, it is not recommended during pregnancy and/or for women planning to become pregnant. According to the manufacturing company, in the United States, each drug package is priced at $712 for a 5-day treatment period. Molnupiravir can be used in outpatients and inpatients (Over 18 years old) with moderate or severe symptoms in the early stages of the disease. But it is not recommended during pregnancy and/or for women planning to become pregnant.

Cites

No record.

References

Cite

APA: Copy

MOBINIZADEH, MOHAMMADREZA, AKBARISARI, ALI, Olyaeemanesh, Alireza, MOHAMMADSHAHI, MARITA, AHMADNEZHAD, ELHAM, ABOEE, PARISA, Fakorfard, Zeinab, & SADEGHI, RAHELEH. (2022). Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review. JOURNAL OF PHARMACEUTICAL CARE, 10(3), 146-150. SID. https://sid.ir/paper/1007071/en

Vancouver: Copy

MOBINIZADEH MOHAMMADREZA, AKBARISARI ALI, Olyaeemanesh Alireza, MOHAMMADSHAHI MARITA, AHMADNEZHAD ELHAM, ABOEE PARISA, Fakorfard Zeinab, SADEGHI RAHELEH. Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review. JOURNAL OF PHARMACEUTICAL CARE[Internet]. 2022;10(3):146-150. Available from: https://sid.ir/paper/1007071/en

IEEE: Copy

MOHAMMADREZA MOBINIZADEH, ALI AKBARISARI, Alireza Olyaeemanesh, MARITA MOHAMMADSHAHI, ELHAM AHMADNEZHAD, PARISA ABOEE, Zeinab Fakorfard, and RAHELEH SADEGHI, “Safety and Effectiveness of Molnupiravir in Covid-19 Treatment: A Rapid Review,” JOURNAL OF PHARMACEUTICAL CARE, vol. 10, no. 3, pp. 146–150, 2022, [Online]. Available: https://sid.ir/paper/1007071/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops